Table 2 Prognostic effect of SHR and ABG on the risk of in-hospital adverse events
Univariate logistic analysis | Multivariate logistic analysis | ROC analysis | |||
|---|---|---|---|---|---|
OR (95% CI) | P value | OR (95% CI) | P value | AUC (95% CI) | |
AKI | |||||
ABG | 1.06 (1.02–1.10) | 0.001 | 1.02 (0.89–1.13) | 0.136 | 0.55 (0.48–0.61) |
SHR | 3.59 (2.31–5.58) | < 0.001 | 3.18 (1.99–5.09) | < 0.001 | 0.64 (0.58–0.69)* |
All-cause death | |||||
ABG | 0.99 (0.93–1.05) | 0.824 | 1.00 (0.94–1.06) | 0.953 | 0.50 (0.42–0.57) |
SHR | 1.97 (1.14–3.42) | 0.015 | 1.83 (1.03–3.23) | 0.038 | 0.59 (0.51–0.66) * |
Cardiogenic shock | |||||
ABG | 1.00 (0.95–1.04) | 0.760 | 0.97 (0.92–1.03) | 0.445 | 0.46 (0.39–0.52) |
SHR | 2.24 (1.45–3.46) | 0.011 | 1.80 (1.12–2.87) | 0.014 | 0.60 (0.54–0.66) * |